Josh Mailman, MBA, Author at Grand Rounds in Urology

Josh Mailman, MBA

NorCal CariciNET Community

Ripon, California

Josh Mailman is President of the Northern California CarciNET Community. He is an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for integrative oncology, nuclear medicine, and molecular imaging. He is the inaugural chairman of the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Patient Advocacy Advisory Board, a member of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) Board, and Treasurer of the Neuroendocrine Tumor Research Foundation. Mr. Mailman has an MBA from the Anderson School of Management at UCLA and has been a technology entrepreneur for more than 20 years.

Disclosures:

Talks by Josh Mailman, MBA

Neuroendocrine Tumors | Not so Rare?

Posted by Josh Mailman, MBA | Aug 2018

Josh Mailman, MBA, the president of NorCal CarciNET, discusses the management of neuroendocrine tumors (NETs) through a patient’s perspective. He reports on overall patients’ attitudes toward Gallium Ga 68-DOTATATE imaging and the newly-approved Lutetium Lu 177 Dotatate therapy, as well as advocacy in the NETs patient community.

Josh Mailman, MBA

NorCal CariciNET Community

Ripon, California

Talks by Josh Mailman, MBA

Neuroendocrine Tumors | Not so Rare?

Join the GRU Community

You have Successfully Subscribed!